Related Experiment Videos

Cardiovascular effects of antipsychotics

James W Michelsen1, Jonathan M Meyer

  • 1University of California, San Diego, Department of Medicine, CA, USA. james.michelsen2@va.gov

Expert Review of Neurotherapeutics
|July 6, 2007
PubMed

Insights

Schizophrenia patients face high cardiovascular risks due to lifestyle and antipsychotic medications. Atypical antipsychotics significantly increase this risk through metabolic side effects like weight gain and diabetes.

Area of Science:

  • Psychiatry
  • Cardiology
  • Pharmacology

Background:

  • Schizophrenia patients exhibit high cardiovascular disease (CVD) mortality.
  • CVD risk is exacerbated by lifestyle factors and comorbidities like dyslipidemia, metabolic syndrome, and Type 2 diabetes.
  • Antipsychotic medications are a significant contributor to cardiovascular risk in this population.

Purpose of the Study:

  • To review the cardiovascular risks associated with antipsychotic medication treatment.
  • To elucidate the mechanisms underlying these risks, particularly metabolic adverse effects.
  • To compare cardiovascular risks among different antipsychotic agents, focusing on atypical antipsychotics.

Main Methods:

  • Literature review of antipsychotic cardiovascular effects.
  • Analysis of mechanisms, including muscarinic cholinergic antagonism, alpha(1)-adrenergic antagonism, and cardiac conduction.
  • Focus on metabolic adverse effects such as weight gain, dyslipidemia, and diabetes mellitus.

Main Results:

  • Cardiovascular risks from antipsychotics include tachycardia, orthostatic hypotension, and sudden death.
  • Since 2000, focus has shifted to metabolic adverse effects.
  • Atypical antipsychotics are particularly associated with weight gain, dyslipidemia, and diabetes mellitus, increasing cardiovascular burden.

Conclusions:

  • Antipsychotic treatment poses significant cardiovascular risks to schizophrenia patients.
  • Metabolic adverse effects, especially from atypical antipsychotics, are a primary driver of this risk.
  • Understanding these risks is crucial for managing cardiovascular health in schizophrenia.

Related Concept Videos

Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications